Forbion Partner Dmitrij Hristodorov, PhD will be attending BioFIT which takes place from 29 - 30 November 2022 in Strasbourg, France.
With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming from public research institutions, academic spin-offs and emerging biotech companies. Together with big pharma, biotech and diagnostic companies, BioFIT operates as a platform to build partnerships for all public and private actors. BioFIT is also the European marketplace for pre-seed, seed and Series A investment in Life Sciences.
Dmitrij will take part on the panel Biotech start-ups: How to pitch the “value” of the investment rather than the science alone" on day 2 (30 November).
Session Background
Funding for cutting-edge scientific discoveries is essential to enable the application of science at the pre-commercial stage. While the scientific breakthrough may be obvious, it is not always sufficient in itself, and identifying the commercial opportunities is essential to convince investors. How is the commercial value of a scientific discovery identified and what to do once it has been defined? How to effectively communicate the potential value of the science – which may not be realised for a long time – to attract talent and raise funds? How do you build trust with potential investors?
To register click here.
